Cargando…
Triac Treatment Prevents Neurodevelopmental and Locomotor Impairments in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice
Patients with inactive thyroid hormone (TH) transporter MCT8 display intellectual disability due to compromised central TH transport and action. As a therapeutic strategy, application of thyromimetic, MCT8-independent compounds Triac (3,5,3′-triiodothyroacetic acid), and Ditpa (3,5-diiodo-thyropropi...
Autores principales: | Chen, Jiesi, Salveridou, Eva, Liebmann, Lutz, Sundaram, Sivaraj M., Doycheva, Denica, Markova, Boyka, Hübner, Christian A., Boelen, Anita, Visser, W. Edward, Heuer, Heike, Mayerl, Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966820/ https://www.ncbi.nlm.nih.gov/pubmed/36834863 http://dx.doi.org/10.3390/ijms24043452 |
Ejemplares similares
-
Thyroid Hormone Transporters MCT8 and OATP1C1 Control Skeletal Muscle Regeneration
por: Mayerl, Steffen, et al.
Publicado: (2018) -
Proteome Analysis of Thyroid Hormone Transporter Mct8/Oatp1c1-Deficient Mice Reveals Novel Dysregulated Target Molecules Involved in Locomotor Function
por: Siemes, Devon, et al.
Publicado: (2023) -
TRIAC Treatment Improves Impaired Brain Network Function and White Matter Loss in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice
por: Reinwald, Jonathan Rochus, et al.
Publicado: (2022) -
Thyroid Hormone Transporter Deficiency in Mice Impacts Multiple Stages of GABAergic Interneuron Development
por: Mayerl, Steffen, et al.
Publicado: (2021) -
Distinct Actions of the Thyroid Hormone Transporters Mct8 and Oatp1c1 in Murine Adult Hippocampal Neurogenesis
por: Mayerl, Steffen, et al.
Publicado: (2022)